Molecular dating of senile plaques in the brains of individuals with down syndrome and in aged dogs

Experimental Neurology

Volumn 163, Issue 1, 2000, Pages 111-122

  Azizeh, Bassem Y ^a   Head, Elizabeth ^a   Ibrahim, Michael A ^a   Torp, Reidun ^b   Tenner, Andrea J ^a   Kim, Ronald C ^a   Lott, Ira T ^a   Cotman, Carl W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Aged dog; Down syndrome; Posttranslational modifications; Racemization; Ultrastructure; amyloid fibrils

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; AGING; ANTIBODY AFFINITY; ANTIBODY LABELING; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOG; DOWN SYNDROME; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN MODIFICATION; SENILE PLAQUE;

EID: 0034102796     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7359     Document Type: Article

References (56)

1. Arai T., Akiyama H., Ikeda K., Kondo H., Mori H. Immunohistochemical localization of amyloid β-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease. Brain Res. 823:1999;202-206.
2. Armstrong R. A., Smith C. U. M. β-Amyloid (β/A4) deposition in the medial temporal lobe in Down's syndrome: Effects of brain region and patient age. Neurobiol. Dis. 1:1994;139-144.
3. Bada J. L. In vivo racemization in mammalian proteins. Methods Enzymol. 106:1984;98-115.
4. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C. W., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
5. Cummings B. J., Cotman C. W. Image analysis of beta-amyloid "load" in Alzheimer's disease and relation to dementia severity. Lancet. 346:1995;1524-1528.
6. Cummings B. J., Head E., Ruehl W. W., Milgram N. W., Cotman C. W. The canine as an animal model of human aging and dementia. Neurobiol. Aging. 17:1996;259-268.
7. Dickson D. W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:1997;321-339.
8. Finch C. E., C. D. M. Aging, metabolism, and Alzheimer's disease: Review and hypothesis. Exp. Neurol. 143:1997;82-102.
9. Fonseca M. I., Head E., Velasquez P., Cotman C. W., Tenner A. J. The presence of isoaspartic acid in β-amyloid plaques indicates plaque age. Exp. Neurol. 157:1999;277-288.
10. Geiger T., Clarke D. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. J. Biol. Chem. 262:1987;785-794.
11. Head E., McCleary R., Hahn F. F., Milgram N. W., Cotman C. W. Region-specific age at onset of β-amyloid in dogs. Neurobiol. Aging. 2000.
12. Hof P. R., Bouras C., Perl D. P., Sparks D. L., Mehta N., Morrison J. H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Arch. Neurol. 52:1995;379-391.
13. Hyman B. T., Marzloff K., Arriagada P. V. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52:1993;594-600.
14. Ikeda S., Yanagisawa N., Allsop D., Glenner G. G. Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry and electron microscopy. Hum. Pathol. 21:1990;1221-1226.
15. Iwatsubo T., Saido T. C., Mann D. M., Lee Y. M., Trojanowski J. Q. Full-length amyloid-β-(1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposits in diffuse plaques. Am. J. Pathol. 149:1996;1823-1830.
16. Johnson B. A., Murray E. D., Clarke S., Glass D. B., Aswad D. W. Protein carboxyl methyltransferase facilitates conversion of atypical l-isoaspartate peptides to l-aspartyl peptides. J. Biol. Chem. 262:1987;5622-5629.
17. Johnson B. A., Shirokowa J. M., Geddes J. W., Choi B. H., Kim R. C., Aswad D. W. Protein l-isoaspartyl methyltransferase in postmortem brains of aged humans. Neurobiol. Aging. 12:1991;19-24.
18. Johnson B. A., Aswad D. W. Kinetic properties of bovine brain protein l-isoaspartyl methyltransferase determined using a synthetic isoaspartyl peptide substrate. Neurochem. Res. 18:1993;87-94.
19. Kang J., Lemaire H. G., Unterbeck A. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
20. Kim E., Lowenson J. D., Maclaren D. C., Clark S., Young S. G. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc. Natl. Acad. Sci. USA. 94:1997;6132-6137.
21. Lemere C. A., Blusztajn J. K., Yamaguchi H., Wisniewski T., Saido T. C., Selkoe D. J. Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3:1996;16-32.
22. Loo D., Copani A., Pike C. J., Whittemore E., Walencewicz A. J., Cotman C. W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
23. Lowenson J. D., Clark S. Recognition of d-aspartyl residues in peptides by the erythrocyte l-isoaspartyl/d-aspartyl protein methyltransferase. Implications for the repair hypothesis. J. Biol. Chem. 267:1992;5985-5995.
24. Lowenson J. D., Roher A. E., Clark S. Protein aging - Extracellular amyloid formation and intracellular repair. Trends Cardiovasc. Med. 4:1994;3-8.
25. Maclaren D. C., O'Connor C. M., Xia Y. R., Mehrabian M., Klisak I., Sparkes R. S., Clark S., Lusis A. J. The l-isoaspartyl/d-aspartyl protein methyltransferase gene (PCMT1) maps to human chromosome 6q22.6q24 and the syntenic region of mouse chromosome 10. Genomics. 14:1992;852-856.
26. Mann D. M. Down syndrome and Alzheimer's disease: Towards an understanding of pathogenesis. Hunter A. J., Clarke S. Neurodegeneration. 1992;21-31 Academic Press, San Diego.
27. Mann D. M. A., Esiri M. M. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J. Neurol. Sci. 89:1989;169-179.
28. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
29. Mori H., Ishii K., Tomiyama T., Furiya Y., Sahara N., Asano S., Endo N., Shirasawa T., Takio K. Racemization: Its biological significance on neuropathogenesis of Alzheimer's disease. Tohoku J. Exp. Med. 174:1994;251-262.
30. Motte J., Williams R. S. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down's syndrome brain. Acta Neuropathol. 77:1989;535-546.
31. Otterson O. P. Postembedding immunogold labelling of fixed glutamate: An electron microscopic analysis of the relationship between gold particle density and antigen concentration. J. Chem. Neuroanat. 2:1989;57-66.
32. Payan I. L., Chou S.-J., Fisher G. H., Man E. H., Emory C., Frey W. I. Altered aspartate in Alzheimer neurofibrillary tangles. Neurochem. Res. 17:1992;187-191.
33. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
34. Ritz S., Turzynski A., Schutz H. W. Estimation of age at death based on aspartic acid racemization in noncollagenous bone proteins. Forensic Sci. Int. 69:1994;149-159.
35. Ritz S., Turzynski A., Schutz H. W., Hollmann A., Rochhloz G. Identification of osteocalcin as a permanent aging constituent of the bone matrix: Basis for an accurate age at death determination. Forensic Sci. Int. 77:1996;13-26.
36. Roher A. E., Lowenson J. D., Clarke S., Woods A. S., Cotter R. J., Gowing E., Ball M. J. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits. Implications for the pathology of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;10836-10840.
37. Roher A. E., Lowenson J. D., Clarke S., Wolkow C., Wang R., Cotter R. J., Reardon I. M., Zurcher-Neely A., Heinrikson R. L., Ball M. J., Greenberg B. D. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:1993;3072-3083.
38. Rozemuller J. M., Eikelenboom P., Stam F. C., Beyreuther K., Masters C. L. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol. 48:1989;674-691.
39. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C. L. Amyloid A4 and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1989;1446-1462.
40. Saido T. C., Yamao-Harigaya W., Iwatsubo T., Kawashima S. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci. Lett. 215:1996;173-176.
41. Satou T., Cummings B. J., Head E., Nielson K. A., Hahn F. F., Milgram N. W., Velazquez P., Cribbs D. H., Tenner A. J., Cotman C. W. The progression of beta-amyloid deposition in the frontal cortex of the aged canine. Brain Res. 774:1997;35-43.
42. Schagger H., Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the seperation of proteins in the range of 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
43. Schwarz H., Humbel B. M. Influence of fixatives and embedding media in immunolabelling of freeze-substituted cells. Scann. Microsc. Suppl. 3:1989;57-63.
44. Selkoe D. J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17:1994;489-517.
45. Selkoe D. J. Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
46. Shapira R., Austin G. E., Mirra S. S. Neuritic plaque amyloid in Alzheimer's disease is highly racemized. J. Neurochem. 50:1988;69-74.
47. Stadtman E. R. Covalent modification reactions are making steps in protein turnover. Biochemistry. 29:1990;6323-6331.
48. Stephenson R. C., Clark S. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J. Biol. Chem. 264:1989;6164-6170.
49. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A., St. George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., Neve R. L. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
50. Tekirian T. L., Saido T. C., Markesbery W. R., Russell M. J., Wekstein D. R., Patel E., Geddes J. W. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits. J. Neuropathol. Exp. Neurol. 57:1998;76-94.
51. 23 residue affects the aggregation properties of Alzheimer amyloid β protein analogues. J. Biol. Chem. 269:1994;10205-10208.
52. Torp R., Head E., Milgram N. W., Hahn F., Ottersen O. P., Cotman C. W. Ultrastructural evidence of fibrillar β-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience. 93:2000;495-506.
53. van Lookeren Campagne M., Oestreicher A. B., van der Krift T. P., Gispen W. H., Verkleij A. J. Freeze-substitution and Lowicryl HM20 embedding of fixed rat brain: Suitability for immunogold ultrastructural localization of neuronal antigens. J. Histochem. Cytochem. 39:1991;1267-1279.
54. Wang B., Larson L. Simultaneous demonstration of multiple antigens by indirect immunofluorescence or immunogold staining. Histochemistry. 83:1985;47-56.
55. Yang A., Knauer M., Burdick M., Glabe C. Intracellular Abeta 1-42 aggregates stimulate the accumulation of stable insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270:1995;14786-14792.
56. Yankner B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.